These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Initial experience with ABO-incompatible live donor renal transplantation. Tsai MK; Wu MH; Lo SC; Lai IR; Yu SC; Yuan RH; Lee PH J Formos Med Assoc; 2006 Sep; 105(9):775-9. PubMed ID: 16959628 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis. Han S; Hwang E; Park S; Park U; Kim H; Cho W Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367 [TBL] [Abstract][Full Text] [Related]
5. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation. Sugiyama K; Hyodo Y; Aikawa A Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258 [TBL] [Abstract][Full Text] [Related]
7. Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations. Tydén G; Donauer J; Wadström J; Kumlien G; Wilpert J; Nilsson T; Genberg H; Pisarski P; Tufveson G Transplantation; 2007 May; 83(9):1153-5. PubMed ID: 17496528 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment. Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599 [TBL] [Abstract][Full Text] [Related]
10. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810 [TBL] [Abstract][Full Text] [Related]
11. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report. Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778 [TBL] [Abstract][Full Text] [Related]
12. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation. Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588 [TBL] [Abstract][Full Text] [Related]
16. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation. Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467 [TBL] [Abstract][Full Text] [Related]